Expert perspectives on hot topics in rheumatology. Join world leading experts as they discuss the cutting-edge research influencing your clinical practice.
2nd March 2022
- Lai-Shan Tam: Inflammation and accelerated atherosclerosis – how can we diagnose early?
- George Kitas: The effect of biologic DMARDs on cardiovascular risk in patients with inflammatory rheumatic diseases
2nd February 2022
- Kevin Winthrop: Herpes Zoster
- COVID-19: Xavier Mariette
- Leonard Calabrese: JAK Inhibitors
- Kevin Winthrop: Risk of CV Events and Malignancies with JAK Inhibitors
1st December 2021
- Hendrik Schulze-Koops: JAKi selectivity – Implications for Therapy
- Rieke Alten: JAK inhibition: Current Results, Future Perspectives
- ALL: JAKi in Clinical Practice: Starting and Switching Therapy (Discussion)
3rd November 2021
- Gerd Burmester: EULAR/ACR recommendations in JAK inhibitors
- Johannes Bijlsma: Difficult to treat RA
- Ronald van Vollenhoven: Can JAK inhibitors become first-line therapy for RA? Pros and Cons
6th October 2021
- Nick Shenker: Overview and Prevalence of Pain in RA
- Neil Basu: Mechanisms of Pain in RA
- Peter Taylor: Management of Pain in RA with JAK Inhibitors
1st September 2021
- Professor Vibeke Strand
- Professor Peter Taylor
